Stimuliver ApS
CVR 42597333 · Private limited company (ApS) · Active · Very high risk
Stimuliver ApS is a Private limited company (ApS), founded on , based in Vanløse. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 7.8% over the next 12 months, which is 5.6 times the average for Danish companies. 4 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Aug 2025) shows equity of DKK -22.4m and a net result of DKK -6.1m. CEO: Dagmara Maria Szkolnicka.
Bankruptcy risk for Stimuliver ApS
5.6 × the average (1.41%) · higher risk than 96% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42597333
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (5 years)
- Address
- c/o Joakim Sørensen, Slotsherrensvej 7, 3. tv
2720 Vanløse - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 4 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -936.8% |
| Current ratio | 15% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -2.7m | DKK -4.1m | DKK -2.9m |
| Net profit | DKK -6.1m | DKK -7.4m | DKK -6.4m |
| Equity | DKK -22.4m | DKK -16.3m | DKK -8.9m |
| Total assets | DKK 2.4m | DKK 7.2m | DKK 11.0m |
| Cash | DKK 219k | DKK 4.3m | – |
| Short-term debt | DKK 15.9m | DKK 21.1m | – |
| Avg. employees | 4 | 5 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Sep 2024 – 31 Aug 2025 | 192 | Late | |
| 1 Sep 2023 – 31 Aug 2024 | 186 | Late | |
| 1 Sep 2022 – 31 Aug 2023 | 183 | ||
| 13 Aug 2021 – 31 Aug 2022 | 182 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Dagmara Maria Szkolnicka | Current | |
| Board | David Colin Hay | Current | |
| Board | Dagmara Maria Szkolnicka | Current | |
| Owner (67%) | David Colin Hay | Current | |
| Owner (5%) | J Kryger Holding ApS | Current | |
| Owner (20%) | Dagmara Maria Szkolnicka | Current | |
| Owner (5%) | Church Street ApS | Current | |
| Owner (25%) | Dagmara Maria Szkolnicka | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | David Colin Hay | Current | |
| Founder | Dagmara Maria Szkolnicka | Current |
Address history (1 moves)
| c/o Joakim Sørensen, Slotsherrensvej 7, 3. tv, 2720 Vanløse | |
| Ole Maaløes Vej 3, 3., 2200 København N |
Other companies at the same address
- J B BYG ApS Bankrupt
- J Kryger Holding ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Stimuliver ApS
Has Stimuliver ApS gone bankrupt?
No, Stimuliver ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Stimuliver ApS?
Our model estimates a bankruptcy risk of 7.8% over the next 12 months (very high risk), which is 5.6 times the average for Danish companies.
Who is the CEO of Stimuliver ApS?
Dagmara Maria Szkolnicka is the CEO of Stimuliver ApS.
Who is the auditor of Stimuliver ApS?
Stimuliver ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Stimuliver ApS founded?
Stimuliver ApS was founded on 13 August 2021.
What is the equity of Stimuliver ApS?
Equity was DKK -22.4m according to the annual report for the period ending 31 August 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.